Europe and US market are 2 different worlds. In the US it's a new molecule they had to submit NDA and pay a ton for FDA approval, clinical trials, etc. It's apples to oranges. This place is not that bad, everyone thinks grass is always greener. Ive talked to former colleagues who wish they were still here. When we came over from NVS, there was so much uncertainty and B + L management kept their promise and almost ALL of us were retained. I thank them for that. They did right by the sales team, and paid us the bonuses promised to us. Don't lose perspective, it could've been a whole hell of alot worse. And never forget how badly NVS treated the eyecare sales team after news broke we were being sold. Remember the pretzel head lies? And all the micromanagement? Don't forget that. I'm thankful for B + L!